Josh Long

Denver

Reporter at Informa

Legal and Regulatory Editor at SupplySide Supplement Journal

Journalist, lawyer by training, slow hockey player, cheese curds addict

Articles

Production-Worthy AI With Spring AI 1.0

2 weeks ago | thenewstack.io | Josh Long

Spring AI 1.0 is finally out the door after a long gestation. If you want to try it out, get the bits at the Spring Initializr. The project is a little long in coming because … gestures wildly at the AI landscape. Things are changing too quickly! But we’re finally at a stable place. Spring AI is a framework for AI engineering. When we talk about AI today, we are largely referring to generative AI, where models are able to generate responses in terms of prompts given.
Dietary supplement industry faces steady stream of class action lawsuits

2 months ago | perkinscoie.com | Josh Long

Dietary supplement companies faced 58 new class action lawsuits in 2024, roughly on par with the previous year (62) although far below a record high in 2022, according to an annual report published by the law firm Perkins Coie. Over the last three years, the supplement sector has been targeted with 225 new class action lawsuits, based on Perkins Coie data.
Reduced staff may impact supplement quality and safety standards at FDA

Feb 21, 2025 | newhope.com | Josh Long

Staff cuts in the FDA's Office of Dietary Supplement Programs have prompted concerns about product safety among some industry leaders. Read on for their analyses. Josh Long, Associate editorial director, SupplySide Supplement JournalAt a GlanceThe staff reduction at the FDA is part of the Trump Administration's plan to reduce waste and cut the federal budget. About 700 employees at the FDA have lost their jobs, according to The New York Times.
This Month in Spring - January 2025

Jan 24, 2025 | blogs.vmware.com | Josh Long

Hi, Spring fans! Welcome to another installment of This Month in Spring! It’s the first This Month in Spring of the new year! And we’ve got a ton of good stuff to look at, no doubt, but this installment is also an ample opportunity in which to look at the year that was.. 2024! (we knew ye when…)I write this edition from a desk overlooking the beautiful island of St. Barths, a beautiful island nation in the French Caribbean.
The future of NMN in supplements might be decided in federal court

Jan 17, 2025 | newhope.com | Josh Long

A lawsuit against the government and amended citizen petition filed with the U.S. Food and Drug Administration by the Natural Products Association could determine the future of β-NMN in dietary supplements, with potentially larger implications for innovation in a $67 billion-a-year industry. Josh Long, Associate editorial director, SupplySide Supplement JournalAt a GlanceThe FDA’s interpretation of the drug exclusion clause will affect NMN supplements and other natural ingredients.
FDA bans FD&C Red No. 3 in food, drugs

Jan 15, 2025 | supplysidefbj.com | Josh Long

The decision comes after a petition showed the additive induces cancer in male rats, but FDA said the same risks aren’t applicable to humans. Josh Long, Associate editorial director, SupplySide Supplement JournalAt a GlanceFDA is revoking the authorized uses of Red 3 in food and ingested drugs. A CSPI petition called Red 3 a “carcinogen” and urged FDA to “take immediate action to prohibit” its use. FDA nonetheless faces criticism over waiting so long to ban the dye.
Kratom alkaloid sparks debate at CHAMPS trade show

Dec 3, 2024 | supplysidesj.com | Josh Long

At a trade show in Denver, some industry professionals discussed the burgeoning market for 7-hydroxymitragynine (7-OH), a kratom alkaloid considered a potential opioid alternative. Some expressed concerns over its safety and long-term effects, while a representative of a 7-OH brand described the kratom alkaloid as a "better mouse trap.”Josh Long, Associate editorial director, SupplySide Supplement Journal DENVER — On Sept.
Pharma, dietary supplement interests collide in court over NMN

Dec 2, 2024 | supplysidesj.com | Josh Long

Josh Long, Associate editorial director, SupplySide Supplement Journal A clinical-stage pharmaceutical firm wants to intervene in a lawsuit regarding the legality of an anti-aging ingredient marketed in dietary supplement products, but the trade association that filed the complaint against the U.S. Food and Drug Administration opposes the request. Metro International Biotech LLC told a federal court on Nov.
The Giant Brown Trout of Lake Ontario

Nov 29, 2024 | onthewater.com | Josh Long

Want to catch the brown trout of a lifetime? There are a few places that constantly come to mind:Iceland. New Zealand. Argentina. Chile. New York. Yes, you read that right. Many of the big brown trout you see on your social media feed and in books and magazines are caught in far-flung locations with astronomical price tags for guides and lodging. However, right here in New York we have brown trout in the Lake Ontario watershed that rival, if not exceed, the size of the browns in those distant waters.
Reform-minded surgeon picked by Trump as FDA chief

Nov 25, 2024 | supplysidesj.com | Josh Long

Dr. Marty Makary of Johns Hopkins University has been nominated by President-elect Trump to lead FDA. He has laid out a health care reform agenda in a series of commentaries and books. At a GlanceSurgeon named to head FDA has argued for health care reform. His books have examined how the present system is ‘broken.’Stakeholders seem cautiously optimistic that the pick could benefit the supplement industry.